ClinicalTrials.gg
Sign In

Drug

TQ-B3525 clinical trials

studies test it
11
open now
0
in phase 3
0
first study started
2018

How studies write it

Studies that test it under each name

Name

TQ-B3525
6
TQ-B3525 tablets
2

Development codes

TQB3525
1

Combined with it in one product

TQ-B3525 Tablets, Osimertinib Mesylate Tablets
1

Studies by the year they started

11 studies that test it; most in 2020 (5)

Studies that test TQ-B3525, by start year
YearStudies
20181
20205
20213
20221
20231

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
9

What it is tested for

Each study’s main condition, where its own words name it.

Kidney Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Lymphoma, Large B-Cell, Diffuse
1
Endometrial Neoplasms
1
Sarcoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Breast Neoplasms
1

Who runs them

Industry 10 · Other 1

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (10) · Peking University People's Hospital (1)

Often tested with

Tested in the same studies.

Osimertinib (1) · Fulvestrant (1)

Studies

Open first, then newest update. How each study uses TQ-B3525 is read from its arms, and is right about nine times in ten.

Testing it · 11